Cargando…
Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment
Mutations affecting mTOR or RAS signaling underlie defined syndromes (the so-called mTORopathies and RASopathies) with high risk for Autism Spectrum Disorder (ASD). These syndromes show a broad variety of somatic phenotypes including cancers, skin abnormalities, heart disease and facial dysmorphisms...
Autores principales: | Vasic, Verica, Jones, Mattson S. O., Haslinger, Denise, Knaus, Lisa S., Schmeisser, Michael J., Novarino, Gaia, Chiocchetti, Andreas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624393/ https://www.ncbi.nlm.nih.gov/pubmed/34828352 http://dx.doi.org/10.3390/genes12111746 |
Ejemplares similares
-
Dysregulation of the immune response in TGF-β signalopathies
por: Rodari, Marco M., et al.
Publicado: (2022) -
mTOR, a Potential Target to Treat Autism Spectrum Disorder
por: Sato, Atsushi
Publicado: (2016) -
Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder
por: Onore, Charity, et al.
Publicado: (2017) -
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
por: Thomas, Shilu Deepa, et al.
Publicado: (2023) -
Pleiotropic Effects of mTOR and Autophagy During Development and Aging
por: Schmeisser, Kathrin, et al.
Publicado: (2019)